original ) (raw )Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders
Chii-ruey Tzeng
Frontiers in Endocrinology, 2019
View PDFchevron_right
Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
Roger Hart
Frontiers in Endocrinology
View PDFchevron_right
Efficacy of Growth Hormone Supplementation with Gonadotrophins in IVF/ICSI for Poor Responders; Randomized Controlled Trial
Mohamed Shafeek
2019
View PDFchevron_right
The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: Randomized control trial
Mohamed Hassan
European journal of obstetrics, gynecology, and reproductive biology, 2018
View PDFchevron_right
Predictors of Total Gonadotropin Dose Required for Follicular Growth in Controlled Ovarian Stimulation with Intrauterin Insemination Cycles in Patients with Unexplained Infertility or Male Subfertility
mehmet çınar
Gynecology Obstetrics and Reproductive Medicine, 2011
View PDFchevron_right
New Criteria for the Use of Growth Hormone in the Treatment of Female Infertility: Minireview and a Case Series
Jan Tesarik
EC Gynaecology, 2020
View PDFchevron_right
Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial
Tansu Kucuk
Journal of Assisted Reproduction and Genetics, 2008
View PDFchevron_right
Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization?
Marc Germond
Human Reproduction, 1999
View PDFchevron_right
A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment
peter yong
Fertility and Sterility, 2003
View PDFchevron_right
Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome
fernando bonilla
Human Reproduction, 1999
View PDFchevron_right
Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF/ICSI for poor responders; randomized controlled trial
Mohamed Shafeek
Taiwanese journal of obstetrics & gynecology, 2021
View PDFchevron_right
Effect of growth hormone on oocyte competence in patients with multiple IVF failures
Y. Ménézo
Reproductive BioMedicine Online, 2009
View PDFchevron_right
Adjuvant growth hormone use improves euploid rate in women undergoing IVF/PGT-A who are not poor responders
winifred mak
Fertility and Sterility, 2019
View PDFchevron_right
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
John Yovich
BMJ Open
View PDFchevron_right
Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone
André Hazout
Human Reproduction, 2005
View PDFchevron_right
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study
arianna riva
Fertility and Sterility, 2011
View PDFchevron_right
The Evolving Concept of Poor-Prognosis for Women Undertaking IVF and the Notion of Growth Hormone as an Adjuvant; A Single-Center Viewpoint
John Yovich
Frontiers in Endocrinology
View PDFchevron_right
Comparison of Triggering Final Oocyte Maturation with Follicle Stimulating Hormone Plus Human Chorionic Gonadotropin, versus Human Chorionic Gonadotropin Alonein Normoresponder Women Undergoing Intracytoplasmic Sperm Injection: A Randomized Clinical Trial
Nayereh Tamizi , international journal of fertility and sterility Int J Fertil Steril
Int J Fertil Steril, Vol 16, No 3, July-September , 2022
View PDFchevron_right
Impact of GnRH ovarian stimulation protocols on intracytoplasmic sperm injection outcomes
Cristiano Sousa F
Reproductive Biology and Endocrinology, 2009
View PDFchevron_right
Is growth hormone administration essential for in vitro fertilization treatment of female patients with growth hormone deficiency?
Alice Albu
Systems biology in reproductive medicine, 2018
View PDFchevron_right
Administration of a gonadotropin releasing hormone analogue in oligozoospermic infertile males
Christophe Blockeel , Michel Camus
European Journal of Endocrinology, 1988
View PDFchevron_right
A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders interv...
P. Braude
View PDFchevron_right
A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins
Roberto Marci
Fertility and Sterility, 2001
View PDFchevron_right
Does pituitary suppression affect live birth rate in women with congenital hypogonadotrophic hypogonadism undergoing intra-cytoplasmic sperm injection? A multicenter cohort study
kiper aslan
Gynecological Endocrinology, 2017
View PDFchevron_right
Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Protocol and GnRH Antagonist Protocol: Effects on In-vitro Fertilization in Patients with Poor-responder Diagnosis According to Bologna Criteria
Murat Api
Aegean Journal of Obstetrics and Gynecology, 2021
View PDFchevron_right
A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
Mohammed Agdi
International journal of fertility & sterility
View PDFchevron_right
Microdose Flare-up Gonadotropin-releasing Hormone (GnRH) Agonist Versus GnRH Antagonist Protocols in Poor Ovarian Responders Undergoing Intracytoplasmic Sperm Injection
Semra Kayatas
Journal of reproduction & infertility
View PDFchevron_right
Outcomes of high initial daily doses of gonadotropin in patients with poor ovarian reserve
Ming-Huei Lin , Robert Kuo-Kuang Lee
Taiwanese journal of obstetrics & gynecology, 2010
View PDFchevron_right